291 related articles for article (PubMed ID: 32245350)
1. [The Prognostic Role of Biomarkers in Patients With Chronic Heart Failure].
Kurlianskaya EK; Mrochek AG; Denisevich TL; Kaliadka MG; Russkich II
Kardiologiia; 2020 Feb; 60(1):16-22. PubMed ID: 32245350
[TBL] [Abstract][Full Text] [Related]
2. [Soluble Suppression of Tumorogenicity 2 Increases Opportunities for Risk Stratification After Acute Heart Failure Decompensation].
Skvortsov AA; Protasov VN; Narusov OY; Koshkina DE; Nasonova SN; Masenko VP; Tereschenko SN
Kardiologiia; 2017 Jan; (1):48-58. PubMed ID: 28290833
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of plasma galectin-3 in patients with chronic heart failure.
Chen K; Jiang RJ; Wang CQ; Yin ZF; Fan YQ; Cao JT; Han ZH; Wang Y; Song DQ
Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):1005-11. PubMed ID: 23661512
[TBL] [Abstract][Full Text] [Related]
4. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure.
Rothenburger M; Wichter T; Schmid C; Stypmann J; Tjan TD; Berendes E; Etz C; Pioux A; Löher A; Wenzelburger F; Drees G; Hoffmeier A; Breithardt G; Scheld HH
J Heart Lung Transplant; 2004 Oct; 23(10):1189-97. PubMed ID: 15477114
[TBL] [Abstract][Full Text] [Related]
5. [Heart fatty acid binding protein in patients hospitalized because of worsening heart failure. Relation to prognosis of death].
Mazovets OL; Trifonov IR; Katrukha AG; Bereznikova AV; Medvedeva MV; Deev AD; Gratsianksiĭ NA
Kardiologiia; 2008; 48(1):24-9. PubMed ID: 18260992
[TBL] [Abstract][Full Text] [Related]
6. [Not Available].
Protasov VN; Narusov OY; Skvortsov AA; Protasova DE; Kuznetsova TV; Petrukhina AA; Masenko VP; Tereshchenko SN
Kardiologiia; 2019 Jan; 59(1S):53-64. PubMed ID: 30706839
[TBL] [Abstract][Full Text] [Related]
7. [Myocardial and Arterial Stiffness Important Determinant of NT-ProBNP at Development of Heart Failure in Survivors of Myocardial Infarction].
Teplyakov AT; Pyshnikova EY; Andriyanova AV; Kalyuzhin VV; Suslova TE; Nikonova EN; Karpov RS
Kardiologiia; 2016 Apr; 56(4):42-48. PubMed ID: 28294858
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction].
Cao J; Jin XJ; Zhou J; Chen ZY; Xu DL; Yang XC; Dong W; Li LW; Luo J; Chen L; Fu M; Zhou JM; Ge JB
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):875-881. PubMed ID: 31744276
[No Abstract] [Full Text] [Related]
9. NT-proBNP and CA 125 levels are associated with increased pro-inflammatory cytokines in coronary sinus serum of patients with chronic heart failure.
Stanciu AE; Stanciu MM; Vatasescu RG
Cytokine; 2018 Nov; 111():13-19. PubMed ID: 30098475
[TBL] [Abstract][Full Text] [Related]
10. N-terminal pro-brain natriuretic peptide, kidney disease and outcome in patients with chronic heart failure.
Bruch C; Reinecke H; Stypmann J; Rothenburger M; Schmid C; Breithardt G; Wichter T; Gradaus R
J Heart Lung Transplant; 2006 Sep; 25(9):1135-41. PubMed ID: 16962477
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic value of N-terminal-pro-brain natriuretic peptide on admission in patients with chronic heart failure].
Wang F; Li W; Huang J; Wang L; Bian WY; Pang HM; Wang Y; Xu ZM; Li YS
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jan; 34(1):28-32. PubMed ID: 16626545
[TBL] [Abstract][Full Text] [Related]
12. The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure.
Fu S; Xie L; Li D; Ye P; Luo L
Clin Interv Aging; 2015; 10():359-65. PubMed ID: 25670892
[TBL] [Abstract][Full Text] [Related]
13. Acute coronary syndrome in patients with cancer: features of the course and the possibility of predicting hospital and long-term (6 months) periods using GDF-15, NT-proBNP, hs-CRP biomarkers.
Shalenkova MA; Ivanov AV; Klimkin PF
Kardiologiia; 2021 Oct; 61(10):4-13. PubMed ID: 34763634
[TBL] [Abstract][Full Text] [Related]
14. The role of N-terminal pro-B-type natriuretic peptide in the diagnosis of congestive heart failure in children. - Correlation with the heart failure score and comparison with B-type natriuretic peptide -.
Sugimoto M; Manabe H; Nakau K; Furuya A; Okushima K; Fujiyasu H; Kakuya F; Goh K; Fujieda K; Kajino H
Circ J; 2010 May; 74(5):998-1005. PubMed ID: 20378998
[TBL] [Abstract][Full Text] [Related]
15. Old markers, new approach to assessment of risk in heart failure.
Kodziszewska K; Leszek P; Korewicki J; Piotrowski W
Kardiol Pol; 2015; 73(6):387-95. PubMed ID: 25563469
[TBL] [Abstract][Full Text] [Related]
16. The level of NT-proBNP in ambulatory patients with chronic heart failure with preserved ejection fraction of the left ventricle.
Kirillova VV; Sokolova LA; Meshchaninov VN; Pershanova VI
Ter Arkh; 2018 Sep; 90(9):68-72. PubMed ID: 30701738
[TBL] [Abstract][Full Text] [Related]
17. N-Terminal Pro-B-Type Natriuretic Peptide as a Marker of Severity of Heart Failure in Children with Congenital Heart Diseases.
Chowdhury RR; Kaur S; Gera R
Pediatr Cardiol; 2023 Dec; 44(8):1716-1720. PubMed ID: 37563318
[TBL] [Abstract][Full Text] [Related]
18. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
[TBL] [Abstract][Full Text] [Related]
19. [Peak oxygen consumption, NT-proBNP and echocardiographic changes in patients with chronic heart failure].
Lu Z; Sun X; Hu S; Huang J
Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Mar; 43(3):206-11. PubMed ID: 26269338
[TBL] [Abstract][Full Text] [Related]
20. [Therapy of High Risk Patients After Decompensation of Heart Failure Under NT-proBNP Control. Main Results].
Skvortsov AA; Koshkina DE; Narusov OY; Protasov VN; Masenko VP; Tereshchenko SN
Kardiologiia; 2016 Jul; 56(7):25-38. PubMed ID: 28290905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
